Chapter/Section Purchase

Leave This Empty:

Global AI for Pharma and Biotech Market Insights, Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI for Pharma and Biotech Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Deep Learning
1.2.3 Big Data
1.2.4 Image Detection
1.2.5 Others
1.3 Market by Application
1.3.1 Global AI for Pharma and Biotech Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global AI for Pharma and Biotech Market Perspective (2017-2028)
2.2 AI for Pharma and Biotech Growth Trends by Region
2.2.1 AI for Pharma and Biotech Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 AI for Pharma and Biotech Historic Market Size by Region (2017-2022)
2.2.3 AI for Pharma and Biotech Forecasted Market Size by Region (2023-2028)
2.3 AI for Pharma and Biotech Market Dynamics
2.3.1 AI for Pharma and Biotech Industry Trends
2.3.2 AI for Pharma and Biotech Market Drivers
2.3.3 AI for Pharma and Biotech Market Challenges
2.3.4 AI for Pharma and Biotech Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI for Pharma and Biotech Players by Revenue
3.1.1 Global Top AI for Pharma and Biotech Players by Revenue (2017-2022)
3.1.2 Global AI for Pharma and Biotech Revenue Market Share by Players (2017-2022)
3.2 Global AI for Pharma and Biotech Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI for Pharma and Biotech Revenue
3.4 Global AI for Pharma and Biotech Market Concentration Ratio
3.4.1 Global AI for Pharma and Biotech Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI for Pharma and Biotech Revenue in 2021
3.5 AI for Pharma and Biotech Key Players Head office and Area Served
3.6 Key Players AI for Pharma and Biotech Product Solution and Service
3.7 Date of Enter into AI for Pharma and Biotech Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI for Pharma and Biotech Breakdown Data by Type
4.1 Global AI for Pharma and Biotech Historic Market Size by Type (2017-2022)
4.2 Global AI for Pharma and Biotech Forecasted Market Size by Type (2023-2028)
5 AI for Pharma and Biotech Breakdown Data by Application
5.1 Global AI for Pharma and Biotech Historic Market Size by Application (2017-2022)
5.2 Global AI for Pharma and Biotech Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America AI for Pharma and Biotech Market Size (2017-2028)
6.2 North America AI for Pharma and Biotech Market Size by Type
6.2.1 North America AI for Pharma and Biotech Market Size by Type (2017-2022)
6.2.2 North America AI for Pharma and Biotech Market Size by Type (2023-2028)
6.2.3 North America AI for Pharma and Biotech Market Share by Type (2017-2028)
6.3 North America AI for Pharma and Biotech Market Size by Application
6.3.1 North America AI for Pharma and Biotech Market Size by Application (2017-2022)
6.3.2 North America AI for Pharma and Biotech Market Size by Application (2023-2028)
6.3.3 North America AI for Pharma and Biotech Market Share by Application (2017-2028)
6.4 North America AI for Pharma and Biotech Market Size by Country
6.4.1 North America AI for Pharma and Biotech Market Size by Country (2017-2022)
6.4.2 North America AI for Pharma and Biotech Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe AI for Pharma and Biotech Market Size (2017-2028)
7.2 Europe AI for Pharma and Biotech Market Size by Type
7.2.1 Europe AI for Pharma and Biotech Market Size by Type (2017-2022)
7.2.2 Europe AI for Pharma and Biotech Market Size by Type (2023-2028)
7.2.3 Europe AI for Pharma and Biotech Market Share by Type (2017-2028)
7.3 Europe AI for Pharma and Biotech Market Size by Application
7.3.1 Europe AI for Pharma and Biotech Market Size by Application (2017-2022)
7.3.2 Europe AI for Pharma and Biotech Market Size by Application (2023-2028)
7.3.3 Europe AI for Pharma and Biotech Market Share by Application (2017-2028)
7.4 Europe AI for Pharma and Biotech Market Size by Country
7.4.1 Europe AI for Pharma and Biotech Market Size by Country (2017-2022)
7.4.2 Europe AI for Pharma and Biotech Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI for Pharma and Biotech Market Size (2017-2028)
8.2 Asia-Pacific AI for Pharma and Biotech Market Size by Type
8.2.1 Asia-Pacific AI for Pharma and Biotech Market Size by Type (2017-2022)
8.2.2 Asia-Pacific AI for Pharma and Biotech Market Size by Type (2023-2028)
8.2.3 Asia-Pacific AI for Pharma and Biotech Market Share by Type (2017-2028)
8.3 Asia-Pacific AI for Pharma and Biotech Market Size by Application
8.3.1 Asia-Pacific AI for Pharma and Biotech Market Size by Application (2017-2022)
8.3.2 Asia-Pacific AI for Pharma and Biotech Market Size by Application (2023-2028)
8.3.3 Asia-Pacific AI for Pharma and Biotech Market Share by Application (2017-2028)
8.4 Asia-Pacific AI for Pharma and Biotech Market Size by Region
8.4.1 Asia-Pacific AI for Pharma and Biotech Market Size by Region (2017-2022)
8.4.2 Asia-Pacific AI for Pharma and Biotech Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America AI for Pharma and Biotech Market Size (2017-2028)
9.2 Latin America AI for Pharma and Biotech Market Size by Type
9.2.1 Latin America AI for Pharma and Biotech Market Size by Type (2017-2022)
9.2.2 Latin America AI for Pharma and Biotech Market Size by Type (2023-2028)
9.2.3 Latin America AI for Pharma and Biotech Market Share by Type (2017-2028)
9.3 Latin America AI for Pharma and Biotech Market Size by Application
9.3.1 Latin America AI for Pharma and Biotech Market Size by Application (2017-2022)
9.3.2 Latin America AI for Pharma and Biotech Market Size by Application (2023-2028)
9.3.3 Latin America AI for Pharma and Biotech Market Share by Application (2017-2028)
9.4 Latin America AI for Pharma and Biotech Market Size by Country
9.4.1 Latin America AI for Pharma and Biotech Market Size by Country (2017-2022)
9.4.2 Latin America AI for Pharma and Biotech Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI for Pharma and Biotech Market Size (2017-2028)
10.2 Middle East & Africa AI for Pharma and Biotech Market Size by Type
10.2.1 Middle East & Africa AI for Pharma and Biotech Market Size by Type (2017-2022)
10.2.2 Middle East & Africa AI for Pharma and Biotech Market Size by Type (2023-2028)
10.2.3 Middle East & Africa AI for Pharma and Biotech Market Share by Type (2017-2028)
10.3 Middle East & Africa AI for Pharma and Biotech Market Size by Application
10.3.1 Middle East & Africa AI for Pharma and Biotech Market Size by Application (2017-2022)
10.3.2 Middle East & Africa AI for Pharma and Biotech Market Size by Application (2023-2028)
10.3.3 Middle East & Africa AI for Pharma and Biotech Market Share by Application (2017-2028)
10.4 Middle East & Africa AI for Pharma and Biotech Market Size by Country
10.4.1 Middle East & Africa AI for Pharma and Biotech Market Size by Country (2017-2022)
10.4.2 Middle East & Africa AI for Pharma and Biotech Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 CureMetrix
11.1.1 CureMetrix Company Details
11.1.2 CureMetrix Business Overview
11.1.3 CureMetrix AI for Pharma and Biotech Introduction
11.1.4 CureMetrix Revenue in AI for Pharma and Biotech Business (2017-2022)
11.1.5 CureMetrix Recent Developments
11.2 Enlitic
11.2.1 Enlitic Company Details
11.2.2 Enlitic Business Overview
11.2.3 Enlitic AI for Pharma and Biotech Introduction
11.2.4 Enlitic Revenue in AI for Pharma and Biotech Business (2017-2022)
11.2.5 Enlitic Recent Developments
11.3 VoxelCloud
11.3.1 VoxelCloud Company Details
11.3.2 VoxelCloud Business Overview
11.3.3 VoxelCloud AI for Pharma and Biotech Introduction
11.3.4 VoxelCloud Revenue in AI for Pharma and Biotech Business (2017-2022)
11.3.5 VoxelCloud Recent Developments
11.4 Insilico Medicine
11.4.1 Insilico Medicine Company Details
11.4.2 Insilico Medicine Business Overview
11.4.3 Insilico Medicine AI for Pharma and Biotech Introduction
11.4.4 Insilico Medicine Revenue in AI for Pharma and Biotech Business (2017-2022)
11.4.5 Insilico Medicine Recent Developments
11.5 Oncora Medical
11.5.1 Oncora Medical Company Details
11.5.2 Oncora Medical Business Overview
11.5.3 Oncora Medical AI for Pharma and Biotech Introduction
11.5.4 Oncora Medical Revenue in AI for Pharma and Biotech Business (2017-2022)
11.5.5 Oncora Medical Recent Developments
11.6 Atomwise
11.6.1 Atomwise Company Details
11.6.2 Atomwise Business Overview
11.6.3 Atomwise AI for Pharma and Biotech Introduction
11.6.4 Atomwise Revenue in AI for Pharma and Biotech Business (2017-2022)
11.6.5 Atomwise Recent Developments
11.7 TwoXAR
11.7.1 TwoXAR Company Details
11.7.2 TwoXAR Business Overview
11.7.3 TwoXAR AI for Pharma and Biotech Introduction
11.7.4 TwoXAR Revenue in AI for Pharma and Biotech Business (2017-2022)
11.7.5 TwoXAR Recent Developments
11.8 Berg Health
11.8.1 Berg Health Company Details
11.8.2 Berg Health Business Overview
11.8.3 Berg Health AI for Pharma and Biotech Introduction
11.8.4 Berg Health Revenue in AI for Pharma and Biotech Business (2017-2022)
11.8.5 Berg Health Recent Developments
11.9 CloudMedX
11.9.1 CloudMedX Company Details
11.9.2 CloudMedX Business Overview
11.9.3 CloudMedX AI for Pharma and Biotech Introduction
11.9.4 CloudMedX Revenue in AI for Pharma and Biotech Business (2017-2022)
11.9.5 CloudMedX Recent Developments
11.10 Deep Genomics
11.10.1 Deep Genomics Company Details
11.10.2 Deep Genomics Business Overview
11.10.3 Deep Genomics AI for Pharma and Biotech Introduction
11.10.4 Deep Genomics Revenue in AI for Pharma and Biotech Business (2017-2022)
11.10.5 Deep Genomics Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Details
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson AI for Pharma and Biotech Introduction
11.11.4 Johnson & Johnson Revenue in AI for Pharma and Biotech Business (2017-2022)
11.11.5 Johnson & Johnson Recent Developments
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche AI for Pharma and Biotech Introduction
11.12.4 Roche Revenue in AI for Pharma and Biotech Business (2017-2022)
11.12.5 Roche Recent Developments
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer AI for Pharma and Biotech Introduction
11.13.4 Pfizer Revenue in AI for Pharma and Biotech Business (2017-2022)
11.13.5 Pfizer Recent Developments
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis AI for Pharma and Biotech Introduction
11.14.4 Novartis Revenue in AI for Pharma and Biotech Business (2017-2022)
11.14.5 Novartis Recent Developments
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer AI for Pharma and Biotech Introduction
11.15.4 Bayer Revenue in AI for Pharma and Biotech Business (2017-2022)
11.15.5 Bayer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer